About Us

Who is Imunexus

Imunexus Ltd is an Australian antibody enhancement company founded in November 2014 on technologies developed by the founding members, Dr George Kopsidas and the late Dr Phil Jennings.

Imunexus discovers, develops, and commercialises therapies for the treatment of cancer, immunological and other serious diseases by ‘Turbo Charging’ marketed antibodies, Combining marketed antibodies with Imunexus’ proprietary ImunexinTM technology, converting them into bispecific antibodies, enables the Company to potentially improve the clinical effectiveness of many marketed or clinical stage antibodies.